Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taspoglutide in T2DM inadequately controlled with metformin plus pioglitazone
NCT00744367Phase 3Completed
- Sponsor
- Roche
- Start
- Oct 2008
- Primary completion
- Nov 2010
- Modality
- Peptides
- Countries
- 9
01
Overview
A Phase 3 trial of taspoglutide in type 2 diabetes mellitus (T2DM), sponsored by Roche. Started Oct 2008; status: completed.
02
Drugs
taspoglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00744367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00744367.